Jefferson Antônio Leite
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jefferson Antônio Leite has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Niels Olsen Saraiva Câmara
Federal University of São Paulo
3 shared publications - Ari Waisman
Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
2 shared publications - Bruno Ghirotto
Department of Stem Cell Biology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
2 shared publications - Eloisa Martins da Silva
Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
2 shared publications Natalia Notarberardino Bos
Institute for Molecular Medicine, University Medical Center of the Johannes Gutenberg-University Mainz
2 shared publications- Anthony Gabry da Silveira
Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 17 September 2026
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2728329
Gut microbiota dysbiosis shapes brain T-cell immunity in accelerated aging
The bidirectional communication between the gut microbiota, immune system, and central nervous system-the gut‒brain axis-plays a vital role in maintaining brain health. Its disruption can lead to neuroinflammation and cognitive decline. However, the relationship between the gut microbiota and age-related changes in brain immunity remains unclear. This study examined gut microbiota composition and T-cell profiles in senescence-accelerated SAMP8 mice and senescence-resistant SAMR1 controls at young adult and aged stages. The accelerated-aging phenotype of SAMP8 mice was confirmed by reduced behavioral performance and brain transcriptomic alterations. Fecal microbiota profiles were obtained using culture-dependent plating and 16S rRNA gene sequencing. T-cell phenotypes were determined by flow cytometry on brain and splenic leukocytes. Strain, age, and sex were drivers of microbiota composition variation. Microbial diversity differed between strains independently of age. Several bacterial genera had altered abundances in young SAMP8 mice, with only Intestinimonas remaining higher in aged SAMP8. T-cell profiling revealed strain- and age-specific immune signatures. In the brain, SAMP8 mice exhibited a higher CD4⁺/CD8⁺ ratio, and higher levels of pro-inflammatory cytokine-producing CD4⁺ T cells compared to SAMR1. In contrast, the spleens of SAMP8 mice had a lower CD4⁺/CD8⁺ ratio. Only the spleens of aged SAMP8 mice showed increased T-cell activation (effector/naïve ratios) and higher levels of pro-inflammatory cytokine-producing CD4⁺ and CD8⁺ T cells, suggesting age- and tissue-specific immune alterations. Nine bacterial genera correlated with immune cell frequencies and ratios. Notably, Intestinimonas showed a discordant association with the CD4⁺/CD8⁺ ratio in the brain (negative) and spleen (positive). Furthermore, CD8⁺ T cells correlated with microbiota composition variation more strongly than strain, age, and sex. Together, these findings link the gut microbiota to age-dependent immune remodeling in the brain and imply that altered microbial communities could influence pro-inflammatory T-cell responses, thereby contributing to accelerated brain aging.
- 17 September 2026
- Published by Taylor & Francis in Gut Microbes
- Vol. 18 (1) , 2728329
Open AccessGut microbiota dysbiosis shapes brain T-cell immunity in accelerated aging
The bidirectional communication between the gut microbiota, immune system, and central nervous system-the gut‒brain axis-plays a vital role in maintaining brain health. Its disruption can lead to neuroinflammation and cognitive decline. However, the relationship between the gut microbiota and age-related changes in brain immunity remains unclear. This study examined gut microbiota composition and T-cell profiles in senescence-accelerated SAMP8 mice and senescence-resistant SAMR1 controls at young adult and aged stages. The accelerated-aging phenotype of SAMP8 mice was confirmed by reduced behavioral performance and brain transcriptomic alterations. Fecal microbiota profiles were obtained using culture-dependent plating and 16S rRNA gene sequencing. T-cell phenotypes were determined by flow cytometry on brain and splenic leukocytes. Strain, age, and sex were drivers of microbiota composition variation. Microbial diversity differed between strains independently of age. Several bacterial genera had altered abundances in young SAMP8 mice, with only Intestinimonas remaining higher in aged SAMP8. T-cell profiling revealed strain- and age-specific immune signatures. In the brain, SAMP8 mice exhibited a higher CD4⁺/CD8⁺ ratio, and higher levels of pro-inflammatory cytokine-producing CD4⁺ T cells compared to SAMR1. In contrast, the spleens of SAMP8 mice had a lower CD4⁺/CD8⁺ ratio. Only the spleens of aged SAMP8 mice showed increased T-cell activation (effector/naïve ratios) and higher levels of pro-inflammatory cytokine-producing CD4⁺ and CD8⁺ T cells, suggesting age- and tissue-specific immune alterations. Nine bacterial genera correlated with immune cell frequencies and ratios. Notably, Intestinimonas showed a discordant association with the CD4⁺/CD8⁺ ratio in the brain (negative) and spleen (positive). Furthermore, CD8⁺ T cells correlated with microbiota composition variation more strongly than strain, age, and sex. Together, these findings link the gut microbiota to age-dependent immune remodeling in the brain and imply that altered microbial communities could influence pro-inflammatory T-cell responses, thereby contributing to accelerated brain aging.
- Open Access
- 1 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 3157
Th17 cells require the DNA repair sensor xeroderma pigmentosum complementation Group C to control oxidative DNA damage in a murine model
T helper 17 cells play essential roles in mucosal immunity and autoimmunity, yet the mechanisms that protect these cells from oxidative DNA damage remain poorly defined. Here we show, in a murine model, that the nucleotide excision repair sensor Xeroderma Pigmentosum Complementation Group C preserves genomic stability and metabolic fitness during T helper 17 cell differentiation. Loss of this factor reduces interleukin 17 production and increases mitochondrial reactive oxygen species and oxidative DNA damage, resulting in altered metabolic programs. Mechanistically, Xeroderma Pigmentosum Complementation Group C interacts with the base excision repair enzyme 8-oxoguanine DNA glycosylase, and its absence enhances oxidative lesion incision activity, indicating defective coordination between DNA repair pathways. Restoring antioxidant capacity rescues cytokine production and limits DNA damage in deficient cells. Together, these findings identify Xeroderma Pigmentosum Complementation Group C as a key coordinator of DNA repair and redox control required for T helper 17 cell function in inflammatory settings.
- 1 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 3157
Open AccessTh17 cells require the DNA repair sensor xeroderma pigmentosum complementation Group C to control oxidative DNA damage in a murine model
T helper 17 cells play essential roles in mucosal immunity and autoimmunity, yet the mechanisms that protect these cells from oxidative DNA damage remain poorly defined. Here we show, in a murine model, that the nucleotide excision repair sensor Xeroderma Pigmentosum Complementation Group C preserves genomic stability and metabolic fitness during T helper 17 cell differentiation. Loss of this factor reduces interleukin 17 production and increases mitochondrial reactive oxygen species and oxidative DNA damage, resulting in altered metabolic programs. Mechanistically, Xeroderma Pigmentosum Complementation Group C interacts with the base excision repair enzyme 8-oxoguanine DNA glycosylase, and its absence enhances oxidative lesion incision activity, indicating defective coordination between DNA repair pathways. Restoring antioxidant capacity rescues cytokine production and limits DNA damage in deficient cells. Together, these findings identify Xeroderma Pigmentosum Complementation Group C as a key coordinator of DNA repair and redox control required for T helper 17 cell function in inflammatory settings.
- Open Access
- 18 October 2024
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (10) , 1-17
Sirtuin 1 regulates the phenotype and functions of dendritic cells through Ido1 pathway in obesity
Sirtuin 1 (SIRT1) is a class III histone deacetylase (HDAC3) that plays a crucial role in regulating the activation and differentiation of dendritic cells (DCs) as well as controlling the polarization and activation of T cells. Obesity, a chronic inflammatory condition, is characterized by the activation of immune cells in various tissues. We hypothesized that SIRT1 might influence the phenotype and functions of DCs through the Ido1 pathway, ultimately leading to the polarization towards pro-inflammatory T cells in obesity. In our study, we observed that SIRT1 activity was reduced in bone marrow-derived DCs (BMDCs) from obese animals. These BMDCs exhibited elevated oxidative phosphorylation (OXPHOS) and increased extracellular acidification rates (ECAR), along with enhanced expression of class II MHC, CD86, and CD40, and elevated secretion of IL-12p40, while the production of TGF-β was reduced. The kynurenine pathway activity was decreased in BMDCs from obese animals, particularly under SIRT1 inhibition. SIRT1 positively regulated the expression of Ido1 in DCs in a PPARγ-dependent manner. To support these findings, ATAC-seq analysis revealed that BMDCs from obese mice had differentially regulated open chromatin regions compared to those from lean mice, with reduced chromatin accessibility at the Sirt1 genomic locus in BMDCs from obese WT mice. Gene Ontology (GO) enrichment analysis indicated that BMDCs from obese animals had disrupted metabolic pathways, including those related to GTPase activity and insulin response. Differential expression analysis showed reduced levels of Pparg and Sirt1 in BMDCs from obese mice, which was challenged and confirmed using BMDCs from mice with conditional knockout of Sirt1 in dendritic cells (SIRT1∆). This study highlights that SIRT1 controls the metabolism and functions of DCs through modulation of the kynurenine pathway, with significant implications for obesity-related inflammation.
- 18 October 2024
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (10) , 1-17
Open AccessSirtuin 1 regulates the phenotype and functions of dendritic cells through Ido1 pathway in obesity
Sirtuin 1 (SIRT1) is a class III histone deacetylase (HDAC3) that plays a crucial role in regulating the activation and differentiation of dendritic cells (DCs) as well as controlling the polarization and activation of T cells. Obesity, a chronic inflammatory condition, is characterized by the activation of immune cells in various tissues. We hypothesized that SIRT1 might influence the phenotype and functions of DCs through the Ido1 pathway, ultimately leading to the polarization towards pro-inflammatory T cells in obesity. In our study, we observed that SIRT1 activity was reduced in bone marrow-derived DCs (BMDCs) from obese animals. These BMDCs exhibited elevated oxidative phosphorylation (OXPHOS) and increased extracellular acidification rates (ECAR), along with enhanced expression of class II MHC, CD86, and CD40, and elevated secretion of IL-12p40, while the production of TGF-β was reduced. The kynurenine pathway activity was decreased in BMDCs from obese animals, particularly under SIRT1 inhibition. SIRT1 positively regulated the expression of Ido1 in DCs in a PPARγ-dependent manner. To support these findings, ATAC-seq analysis revealed that BMDCs from obese mice had differentially regulated open chromatin regions compared to those from lean mice, with reduced chromatin accessibility at the Sirt1 genomic locus in BMDCs from obese WT mice. Gene Ontology (GO) enrichment analysis indicated that BMDCs from obese animals had disrupted metabolic pathways, including those related to GTPase activity and insulin response. Differential expression analysis showed reduced levels of Pparg and Sirt1 in BMDCs from obese mice, which was challenged and confirmed using BMDCs from mice with conditional knockout of Sirt1 in dendritic cells (SIRT1∆). This study highlights that SIRT1 controls the metabolism and functions of DCs through modulation of the kynurenine pathway, with significant implications for obesity-related inflammation.
- Open Access
- 24 May 2021
- Published by Wiley in British Journal of Pharmacology
- Vol. 179 (8) , 1496-1511
Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders
Histone deacetylases (HDACs) are enzymes that regulate several processes, such as transcription, cell proliferation, differentiation and development. HDACs are classified as either Zn2+‐dependent or NAD+‐dependent enzymes. Over the years, experimental and clinical evidence has demonstrated that HDAC modulation is a critical process in neurodegenerative and psychiatric disorders. Nevertheless, most of the studies have focused on the role of Zn2+‐dependent HDACs in the development of these diseases, although there is growing evidence showing that the NAD+‐dependent HDACs, known as sirtuins, are also very promising targets. This possibility has been strengthened by reports of decreased levels of NAD+ in CNS disorders, which can lead to alterations in sirtuin activation and therefore result in increased pathology. In this review, we discuss the role of sirtuins in neurodegenerative and neuropsychiatric disorders as well the possible rationale for them to be considered as pharmacological targets in future therapeutic interventions.LINKED ARTICLES: This article is part of a themed issue on Building Bridges in Neuropharmacology. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.8/issuetoc
- 24 May 2021
- Published by Wiley in British Journal of Pharmacology
- Vol. 179 (8) , 1496-1511
Open AccessSirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders
Histone deacetylases (HDACs) are enzymes that regulate several processes, such as transcription, cell proliferation, differentiation and development. HDACs are classified as either Zn2+‐dependent or NAD+‐dependent enzymes. Over the years, experimental and clinical evidence has demonstrated that HDAC modulation is a critical process in neurodegenerative and psychiatric disorders. Nevertheless, most of the studies have focused on the role of Zn2+‐dependent HDACs in the development of these diseases, although there is growing evidence showing that the NAD+‐dependent HDACs, known as sirtuins, are also very promising targets. This possibility has been strengthened by reports of decreased levels of NAD+ in CNS disorders, which can lead to alterations in sirtuin activation and therefore result in increased pathology. In this review, we discuss the role of sirtuins in neurodegenerative and neuropsychiatric disorders as well the possible rationale for them to be considered as pharmacological targets in future therapeutic interventions.LINKED ARTICLES: This article is part of a themed issue on Building Bridges in Neuropharmacology. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.8/issuetoc